ABT-431, a D1 receptor agonist prodrug, has efficacy in Parkinson's disease

O. Rascol, O. Blin, C. Thalamas, S. Descombes, C. Soubrouillard, P. Azulay, N. Fabre, F. Viallet, K. Lafnitzegger, S. Wright, J. H. Carter, J. G. Nutt

Research output: Contribution to journalArticlepeer-review

88 Scopus citations

Fingerprint Dive into the research topics of 'ABT-431, a D1 receptor agonist prodrug, has efficacy in Parkinson's disease'. Together they form a unique fingerprint.

Medicine & Life Sciences